If you have less than a minute:
- Nearly half of the UK adult population has had one vaccine dose - which is more than 25 million people.
- Biden administration eyes mid-May to begin relaxing travel restrictions, as more states expand eligibility for vaccinations and the pace of daily shots steadily increases.
- The European Union health regulator has confirmed that the AstraZeneca vaccine is safe and effective. Vaccinations in the EU using the AZ vaccine have resumed.
- Most people who recover from Covid-19 remain shielded from the virus for at least six months, researchers reported on Wednesday in a large study from Denmark. Another study published in the Lancet medical journal shows Coronavirus reinfections are rare, except in people 65 and older.
- A promising treatment for Covid-19 has been discovered: the evaluation of clofazimine as an at-home treatment for COVID-19 in a phase 2 study could begin immediately. It’s also been found that low-dose aspirin may help protect the lungs and reduce the risk of death of Covid-19, a team at George Washington University reported.
- A single shot of either the Pfizer or Oxford vaccine provides about 80 per cent protection against illness requiring hospital treatment, according to the latest data from the UK vaccination programme. Meanwhile, a new study from Oxford University confirms AstraZeneca, Pfizer COVID-19 vaccines are effective against variants.
- Surveillance indicators suggest that COVID-19 activity continued to decrease across most indicators in week 10 of 2021. Hospital admission rates for COVID-19 have fallen across all regions, and are at their lowest point of the pandemic in Wales.
- Scotland’s vaccination program has delivered first doses of the vaccine to more than two million people – 44% of the adult population. People aged 50-54 are now being invited for a jab in England. This is the final group on the priority list, which covers 99% of those at high risk of dying from Covid-19.
- UK Government announced a £7 billion package for health and care services to support the next phase of the NHS response to COVID-19.
- More states have expanded eligibility for vaccinations: the pace of daily shots administered in the United States has steadily increased to a pace that is now 12 percent higher than it was just a week ago.
- Biden administration eyes mid-May to begin relaxing Covid travel restrictions. The relaxation of restrictions would involve travel across the Mexican and Canadian borders and on inbound travel from the U.K., Europe, and Brazil.
- The United States plans to send 2.5 million doses of AstraZeneca the vaccine to Mexico and 1.5 million to Canada.
- EU states are to resume AstraZeneca vaccine roll-out as Europe's medicines regulator concluded it was "safe and effective".
- With testing of the AstraZeneca vaccine complete, Taiwan plans to start its inoculation campaign against the coronavirus this Monday (March 22).
- Global COVID-19 cases have fallen significantly since they peaked in early January. Scientists are asking whether this is the beginning of the end of the pandemic.